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Background: Hyperuricemia (HUA) is a potential risk factor for developing insulin resistance, hypertension,
dyslipidemia and cardiovascular disease. Therefore, we studied the prevalence of HUA and associated risk factors in
the population of two provinces in northern China.
Methods: Based on the research of Chinese Physiological Constant and Health Conditions conducted in
2008–2010, we enrolled 29,639 subjects in a randomized, stratified study in four sampling areas in Heilongjiang
Province and the Inner Mongolia Autonomous Region. We collected 13,140 serum samples to determine
biochemical indicators including uric acid(UA), glucose, blood lipids, liver function, and renal function, and finally a
representative sample of 8439 aged 18 years and older was determined. We also defined and stratified HUA,
hypertension, diabetes, obesity and lipid abnormalities according to international guidelines.
Results: There were significant differences in the UA levels between different genders and regions. The total
prevalence of HUA is 13.7%. Men had a higher prevalence of HUA than women (21% vs. 7.9%; P < 0.0001). As age
increased, HUA prevalence decreased in men but rose in women. The suburbs of big cities had the highest HUA
prevalence (18.7%), and in high-prevalence areas the proportion of women with HUA also increased. A stepwise
logistic regression model was used to filter out twelve HUA risk factors, including age, gender, residence,
hypercholesterolemia, hypertriglyceridemia, impaired fasting glucose, hypertension, obesity, abdominal obesity, CKD,
drinking and sleeping. After adjusting for these factors, the odds ratio of HUA was 1.92 times higher in men than in
women. Compared with agricultural and pastoral areas, the odds ratio of having HUA was 2.14 for participants in
the suburbs of big cities and 1.57 in the center of big cities.
Conclusions: The prevalence of HUA is high in northern China. The differences in HUA prevalence by geographic
region suggested that unbalanced economic development and health education, therefore HUA prevention
measures should be strengthened to improve quality of life and reduce health care costs.
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Uric acid is the final product of purine metabolism in
humans. However, the pathophysiology of hyperuricemia
(HUA) or elevated serum uric acid (SUA) levels is not
clearly understood. It has been reported that 18.8% of the
patients with HUA developed into gout in a 5 year follow-
up [1]. For years, HUA has been thought to be the same as
gout, but elevated SUA levels have now been identified as a
potential risk factor for developing insulin resistance, hyper-
tension, dyslipidemia and cardiovascular diseases which are
characterized as the so-called metabolic syndrome [2-6]. It
has also been reported that prevalence of the metabolic
syndrome increases substantially with increasing levels of
serum uric acid [7]. Although SUA levels are usually higher
in males than in females, there is a noted increase in SUA
levels in both sexes with increasing age [8].
The prevalence and incidence of HUA in the world
population have steadily increased over the past 40 years
[9]. With rapid economic development and prolonged life
expectancy, study of the HUA in China and other develop-
ing countries has become even more important. Studies of
the prevalence of HUA and its relationship with metabolic
syndrome in healthy Thai adults suggested that the preva-
lence of HUA was 10.6% in the overall Thai population,
and up to 24.4% among those in Bangkok. In addition, a
direct relationship between the level of uric acid and the
prevalence of metabolic syndrome was observed [10,11].
In the study of prevalence of HUA and its association with
antihypertensive treatment in Taiwanese hypertensive sub-
jects, Chung-Sheng Lin et al. found hypertensive subjects
had a higher prevalence of HUA [12]. Several large surveys
have yielded prevalence estimates for HUA in the Chinese
mainland, mainly among populations of coastal cities
[13,14]. However, little information is available about the
HUA prevalence in areas inhabited by Chinese ethnic mi-
norities. Furthermore, most of the studies about HUA
prevalence in China concerned the eastern, especially in
the urban areas and these populations lack of representa-
tiveness [15], therefore, the cohort study with larger sam-
ple is necessary. Besides, currently there is little data
available on the differences in HUA prevalence by geo-
graphic region.
The main objective of this study was to estimate the
trends of SUA levels and prevalence of HUA based on
the recent, nationally representative samples of Chinese
men and women (the Chinese Physiological Constant
and Health Conditions (CPCHC) 2008–2010). We also




The population-based cross-sectional survey, Chinese
Physiological Constant and Health Condition (CPCHC),was conducted during 2008 and 2010. Our research used
the samples from Heilongjiang Province (2008) and Inner
Mongolian Autonomous Region (2010) in this survey. To
maximize the accuracy of prevalence estimates, subjects
were selected using a random, multistage cluster sampling
scheme in four regions of each province selected
according to administrative and economic levels. The four
regions of Heilongjiang and Inner Mongolia are Harbin
city, Harbin suburbs, Mudanjiang, Hailin and Hohhot,
Ulanqab City, Xilin Gol League, Bayannur, which belong
to big cities, suburb of big cities, small and medium-sized
cities and rural and pastoral areas respectively according
to population and economics. Written informed consent
was obtained from each participant before data collection.
The protocol was approved by the Institutional Review
Board of the Institute of Basic Medical Sciences, Chinese
Academy of Medical Sciences.
Inclusions and exclusions
The 2008–2010 CPCHC samples included 29,639 appar-
ently healthy participants. Those who suffered from sys-
temic disease involving diabetes mellitus, hypertension or
other cardiovascular, renal, gastro-intestinal, pulmonary
disease or cancer were excluded. Moreover, participants
taking any medication known to affect carbohydrate and
lipid metabolism were also excluded. Of the total number
of participants, 44.3% (n = 13,140) were selected randomly
to complete blood testing. After excluding individuals aged
< 18 years, where the important variables was missing, and
the results of biochemical tests exceeded four times the
standard deviation of the sample, our final sample size was
8,439 adults (3,725 men and 4,714 women), of which 5,859
were Han Chinese, 954 were Korean-Chinese, 1,292 were
Mongolian-Chinese, and 334 were of other ethnicity.
Data collection and anthropometry
A standard questionnaire was used to obtain demo-
graphic characteristics (age, gender, and ethnicity), socio-
economic data (education level, marital status, and
occupation), lifestyle, past medical history, and lifestyle
risk factors (diet, exercise, smoking, and drinking).
Body weight was measured to the nearest 0.1 kg on a
calibrated beam scale and height was measured to the
nearest 0.1 cm barefoot in triplicate using a wall-
mounted stadiometer. Body mass index (BMI, an index
for overall obesity) was calculated as body weight (in
kilograms) divided by height (in square meters). Waist
circumference (WC) was measured midway between
the lower rib margin and the iliac crest at the end of a
gentle expiration. Blood pressure was measured after
the participant had rested quietly for at least 10 mi-
nutes, using an electric sphygmomanometer (OMRON,
HEM-7000). Blood pressure was measured three times
and the measurements were averaged. When subjects
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was performed to exclude secondary hypertension. All
personnel who participated in data collection and an-
thropometry were trained medical personnel, and all
devices were calibrated.Laboratory measurements
All procedures were performed following a 9–12 hour
overnight fast and all subjects were told to take bland
diet before blood testing. Blood was drawn from the
antecubital vein of the arm. Total cholesterol (TC), tri-
glycerides (TG), high-density lipoprotein cholesterol
(HDL-C) and low-density lipoprotein cholesterol (LDL-
C) were measured with a Beckman AU Series Automatic
Biochemical Analyzer (Japan), using Sekisui Medical
(Japan) reagents. Uric acid (UA), Fasting blood glucose
(FBG), creatine, and 17 other biochemical tests were
measured with the same instrument, using Beckman AU
reagents. All laboratories participating in the survey
followed the same internal quality control program that
was standardized by the Peking Union Medical College
Hospital. Estimated Glomerular Filtration Rate (eGFR)
was calculated by the CG/BSA formula [16].Definition or classification of HUA and other metabolism
dysfunction
HUA was defined as SUA ≥ 416.4 μmol/L (male) or SUA
≥ 356.9 μmol/L (female). Blood pressure was classified as
normotensive (SBP < 120 mmHg and DBP < 80 mmHg),
pre-hypertensive (SBP: 120–139 mmHg and/or DBP:
80–89 mmHg) and hypertensive (SBP ≥ 140 mmHg
and/or DBP ≥ 90 mmHg) by the Seventh Report of the
Joint National Committee on the Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure
(JNC-7). Body mass index (BMI: kg/m2) was calculated
from measured weight and height. BMI was classified as
underweight (< 18.5 kg/m2), normal (18.5–25 kg/m2), over-
weight (25–30 kg/m2) and obese (> 30 kg/m2) by WHO
criteria. Abdominal obesity was defined as WC ≥ 90 cm
(male) or WC ≥ 80 cm (female) by IDF consensus. The
American Diabetes Association criteria was used to classify
FBG as normal glucose (FBG < 5.6 mmol/L), impaired
fasting glucose (IFG) (FBG ≥ 5.6 mmol/L ≤ FBG <
7.0 mmol/L), and diabetic (FBG ≥ 7.0 mmol/L).
Dyslipidemia was classified according to ATP III, TG: Nor-
mal < 1.69 mmol/L, Borderline high 1.69–2.26 mmol/L,
High 2.26–5.65 mmol/L, Very high ≥ 5.65 mmol/L; TC:
Desirable < 5.17 mmol/L, Borderline high 5.17–6.24 mmol/
L, High ≥ 6.24 mmol/L; HDL-C: High 1.56 mmol/L, Opti-
mal 1.03–1.56 mmol/L, Low <l.03 mmol/L; LDL-C: Opti-
mal <2.59 mmol/L, Near optimal 2.59–3.38 mmol/L,
Borderline high 3.38–4.16 mmol/L, High 4.16–4.94 mmol/
L, Very high ≥4.94 mmol/L.Statistical analysis
Epidata 3.2 was used for data entry and verification. Data
were entered twice by two different people, and inconsist-
encies were checked with the original records. SAS 9.2
was used for data processing and statistical analysis. For
univariate analyses, SUA levels and the prevalence of
HUA were described by gender, age and regional groups.
Hyperuricemia was considered as the outcome variable,
and 7 demographic indicators, 18 habits (including smok-
ing, drinking, labor work, exercise, diet habit, sleeping,
and sitting time etc.), 37 parameters on health status (in-
cluding medical history, sub-health state) and 9 metabolic
markers obtained through physical examination and bio-
chemical tests were set as predictor variables. In multivari-
ate analyses, factors that may affect uric acid or HUA were
introduced into a logistic regression model. Sub-health
and past medical history factors were not included in the
model because of a large amount of missing data. The
main factors include demographic information, metabolic
indicators, and behavioral factors of life including eating
habits, physical exercise, smoking and drinking status,
sleep time and other factors. The impact of sub-health and
medical history on HUA was confirmed by univariate ana-
lysis and expert judgment. Mean ± standard deviation was
used to describe the levels of uric acid, which is continuous
variable with a normal distribution. Prevalence (%) indi-
cates the percentage of healthy Chinese men and women
with a condition at the time of data collection. Quantitative
indicator comparison was conducted by t-test, and analysis
of variance (ANOVA) with the Student-Newman-Keuls
(SNK) post-test was used for group comparisons. Results
between men and women were compared using the χ2
test. Qualitative data were compared by chi-square
partitioning to allow α correction; P < 2α / n (n - 1) was
considered statistically significant. The research applied
binary multi-factor and non-conditional logistic regression
models with stepwise regression. The entering criterion for
the logistic regression models was 0.05, and the exclusion
criterion was 0.10, to obtain the optimal model for the
evaluation of the risk factors for HUA. Odds ratios (OR)
and 95% confidence intervals (CI) were calculated to study
the associations between various risk factors and HUA.
P <0.05 was considered statistically significant.
Results
Distribution of uric acid levels
In men, the average uric acid level over the age of 55 was
lower than that under 55, but there were no statistically
significant differences between average uric acid levels
aged 18–24, 25–34, 35–44, 45–54 years and aged 55–64,
65–74, over 75 years respectively (Table 1). In women, the
average uric acid levels gradually increased over 45 years
of age. Uric acid levels in all age groups were significantly
higher in men than that in women (P <0.01), and the total
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women (357.7 μmol/L versus 263.2 μmol/L, P < 0.0001)
(Table 1 and Additional file 1: Figure S1). Among four dif-
ferent regions, uric acid levels in suburbs of big cities were
highest in men, women and the entire study population
(Table 1). Participants from small and medium-sized cities
and agricultural and pastoral areas have lower average uric
acid levels (294.5 μmol/L and 295.6 μmol/L) than that
from the center of big cities and suburbs of big cities
(309.2 μmol/L and 325.7 μmol/L, P < 0.05). There were
no significant differences between uric acid levels in par-
ticipants from small and medium-sized cities and those
from rural and pastoral areas (Table 1). In different ethnic
groups, there were significantly differences between uric
acid levels in women and the entire study population but
no statistical significance in men by SNK test.
Prevalence of hyperuricemia
As shown in Table 2, the total prevalence of HUA is
13.7%. Men had a higher prevalence of HUA than
women (21% vs. 7.9%; P < 0.0001). In men, the HUA
prevalence decreased with increasing age. In women,
HUA prevalence increased in those over 45 years old. In
participants over 65 years old, HUA prevalence in men
and women was similar (P > 0.05). In those over 75 years




18-24 yrs 548 363.7±76.0a
25-34 yrs 584 372.9±79.2a
35-44 yrs 756 364.5±77.3a
45-54 yrs 808 358.4±80.6a
55-64 yrs 511 334.1±77.4b
65-74 yrs 414 340.1±83.2b
> 75 yrs 104 341.4±77.1b
Total 3725 357.7±81.6
Region
Center of big cities 812 363.1±75.8a
Suburbs of big cities 778 374.5±78.2b
Small and medium cities 876 347.2±77.9c





a b c: same letter showed that no difference was found between two age groups, tw
*T test results of comparison with men, P < 0.01.
M mean and SD standard deviation.not significantly higher (P > 0.05) (Table 2). In different
regions, the prevalence of HUA in men was significantly
higher than women and the suburbs of big cities have
the highest HUA prevalence in male (28.0%), female
(14.0%) and total (20.3%). In men, the HUA prevalence
in agricultural and pastoral areas (18.5%) versus small
and medium-sized cities (17.1%) was not significantly
different (P > 0.05). However, HUA prevalence in the
center of big cities (22.6%) and suburbs of big cities
(28.0%) was significantly higher than agricultural and
pastoral areas, as well as significantly higher than small
and medium-sized cities. In women, the prevalence ten-
dency of all regions was similar with men (Table 2). It
was also found that, in areas with higher HUA preva-
lence, the proportion of female patients was significantly
higher, which were 25.7% and 28.7% in small and
medium-sized cities and rural and pastoral areas respect-
ively, while in the metropolitan central area and subur-
ban, the HUA prevalence ratio in female are 34.1% and
37.8% respectively (Figure 1).
Risk factors for HUA
After stepwise logistic regression screening, 12 variables
remained in the model. These were gender, area of resi-
dence, age group, hypercholesterolemia, hypertriglyc-
eridemia, impaired fasting glucose, hypertension, obesity,d ethnic
Female Total
N M±SD(μmol/L) N M±SD(μmol/L)
684 264.9±56.4a * 1232 308.8±82.1
746 247.9±56.7b * 1330 302.8±91.7
944 249.5±56.0b * 1700 300.5±87.5
1053 263.7±61.2a * 1857 304.7±84.5
753 273.5±64.3a * 1264 298.0±75.9
454 291.1±73.3c * 868 314.4±81.8
80 296.5±84.5c * 184 321.9±83.2
4714 263.3±62.6* 8439 305.0±85.6
1111 269.8±63.3a * 1923 309.2±82.8a
953 285.8±65.0b * 1731 325.7±83.8b
1068 253.4±55.1c * 1944 295.6±81.1c
1582 251.8±61.1c * 2832 294.5±86.0c
3197 267.8±62.1a * 5859 309.7±85.2a
760 247.8±60.8b * 1292 290.3±84.5b
567 257.1±66.0c * 954 294.1±88.6b
o regions or two ethnic groups of a same gender with the SNK test.
Table 2 Prevalence of HUA by age and gender
Male Female Total
n Prevalence(%) n Prevalence(%) n Prevalence(%)
Age group
18-24 yrs 116 21.2 49 7.2# 165 13.4
25-34 yrs 157 26.9 35 4.7# 192 14.4
35-44 yrs 177 23.4 48 5.1# 225 13.2
45-54 yrs 178 22.0 73 6.9# 251 13.5
55-64 yrs 70 13.7 71 9.4# 141 11.2
65-74 yrs 70 16.9 77 17.0 147 16.9
>75 yrs 16 15.4 20 25.0 36 19.6
Total 784 21.0 373 7.9# 1157 13.7
Region
Center of big cities 184 22.6 95 8.6# 279 14.5
Suburbs of big cities 219 28.0 133 14.0# 352 20.3
Small and medium cities 150 17.1 52 4.9# 202 10.4
Agricultural and pastoral areas 231 18.5 93 5.9# 324 11.4
#Chi-square test results compared with men, P<0.01.
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Pearson goodness of fit showed a good model fitness
(P = 0.9896). In the fully adjusted model with these 12
co-variables, the odds of women having HUA was 0.52
(0.42–0.64) times the odds of men (Table 3). Partici-
pants in the suburbs of big cities have an odds of HUA
2.14 (1.71–2.68) times that of the agricultural and pas-
toral areas, while those in the center of big cities haveFigure 1 The proportion of male and female in areas with different Han odds of HUA 1.57 (1.25–1.98) times that of the agri-
cultural and pastoral areas. With an increase in lipid
levels, the odds of HUA also increased. Compared with
the control group, the odds of HUA in the hypercholes-
terolemia group was 1.48 (1.12–1.94). Similarly, com-
pared with the control group the odds ratio of HUA in
the hypertriglyceridemia group was 4.30 (2.69–6.86).
The fasting glucose impairment group had an odds ofUA prevalence.
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respective control group, while the diabetic group had an
odds of HUA 0.59 (0.40–0.86) times of the normal glucose
group. The odds of HUA in the hypertensive group was
1.53 (1.18–1.99) times the odds of the normotensive
group. The odds of HUA increased along with an in-
crease in obesity; the odds of HUA in the obese group
was 2.42 (1.73–3.39) times the odds of the normal
weight group. Compared with the respective control
group, the odds ratio of the abdominal obesity group
1.82 (1.46–2.26). As the CKD classification increased,
the odds of HUA also increased. The CKD3 class had an
HUA odds 6.34 (3.96–10.13) times higher than that of
the control group. The odds ratio of HUA in partici-
pants who drink group was 1.36 (1.11–1.67) times the
non-drinking group. The group with less than four
hours of sleep had an odds of HUA 2.48 (1.39–4.42)
times the control group.
Odds ratios for various risk factors were also calculated
separately for men and women (Additional file 1: Table S1
and Table S2). After stepwise logistic regression screening
for men, 13 variables remained in the model. These were
residence, work status, age group, cholesterol level, triglyc-
erides, fasting glucose, obesity, CKD, abdominal obesity,
diet, sleep time, drinking, and physical exercise. The fully
adjusted model indicates that abdominal obesity, hypertri-
glyceridemia and less sleep time are associated with higher
odds of HUA. Oppositely, bland diet group has less odds
of HUA. For women, eight variables remained in the
model: age group, area of residence, triglycerides, low-
density lipoprotein cholesterol, high blood pressure, obes-
ity, CKD, and abdominal obesity. Menopause status was
included as a possible co-variable, but was not selected by
the stepwise regression for inclusion in the final model.
Unlike the general population and men, impaired fasting
glucose and total cholesterol level were not selected for in-
clusion into the model for women. Compared with LDL-
C < 2.59 mmol/L, the odds ratio of HUA of LDL-
C > 3.38 mmol/L was elevated. The impact of residence
was also significant for women: compared with the odds
of HUA of participants living in agricultural and pastoral
areas, the odds ratio of HUA in the suburbs of big cities
was 3.52 (2.35–5.28) and in the center of big cities was
2.24 (1.47–3.40).
Discussion
In the current study, two Chinese Northern provinces
have relatively high HUA prevalence levels of 13.7%
(21.1% in men and 7.9% in women). In the suburbs of
big cities with higher standards of living, the HUA levels
reach 20.3%, while HUA is only 10.4% in small and
medium-sized cities with lower standards of living. To
our knowledge, this was the first study to examine the
differences in HUA prevalence by geographic region inareas inhabited by Chinese ethnic minorities. Our find-
ings suggest that improved living standards bring about
a series of changes in nutrition and metabolism which
may have significant impact on HUA. In recent years,
dozens of surveys on HUA prevalence in mainland
China have been conducted [15]. These surveys may not
be representative of the entire Chinese population, be-
cause most of the study populations are with specific oc-
cupations such as state owned factories and mines
laborers, or from specific regions such as coastal areas.
Seven of these surveys applied randomized sampling,
and these studies showed that the HUA prevalence in
mainland China ranges from 9.2% to 25.6% in men and
1.3% to 15.3% in women, with significant differences in
different areas [17-23]. Surveys in four regions of the
Shandong coastal areas presented HUA prevalence
ranges from 5.5% to 18.1% [18,19]. In the developed
areas of inland Chengdu, the HUA prevalence is 15.6%
[22], while in underdeveloped inland Yan’an City the
prevalence is 5.4% [23]. According to our results and
other published data, we concluded that the HUA preva-
lence is related to the level of regional economic devel-
opment and living standards, not whether it is a coastal
area. Of interest, in a big city the lifestyle and eating in
the suburbs is similar to the city center, but HUA preva-
lence is higher in the suburbs, which may be because
more health education is received in central urban area.
Similar to other researchers [24], we observed that HUA
prevalence in women increased post menopause, which is
consistent with estrogen protection and renal function in
women gradually decreasing with age. However, meno-
pausal status was not selected in the stepwise logistic re-
gression model, possibly because of missing data (Of all
4714 women, 305 women missed the response to “meno-
pausal status”). In participants aged over 75 years old, the
HUA prevalence was higher for women than men. This
may be because the decline in renal function of elderly
women is faster, resulting in poor HUA buffering capacity.
Alternatively, because of a small number of participants in
this age group, the estimates presented here may lack reli-
ability. Interestingly, the UA levels are high in young men.
These high levels may be associated with high androgen
levels in young adults, which promote kidney uric acid re-
absorption [25]. Unlike other reports [21], this study con-
cluded that the lowest HUA prevalence for men is found
in participants aged 55–64, and possible causes include
that Chinese men of this phase are retired. At this age
heavy labor and mental work also decrease, along with
lifestyle changes and more attention on health. All of these
factors could contribute to the relative control of uric acid
levels at age 55–64.
Many studies have reported relationships between
HUA prevalence and hypertension, high blood sugar,
obesity and abnormal lipid metabolism and other
Table 3 HUA risk factors in two Northern Chinese provinces
Factors n % ORa 95% CIa
Gender
Male 784 21.1 1.00
Female 373 7.9 0.52 0.42-0.64
Residence
Agricultural and pastoral areas 324 11.4 1.00
Small and medium sized cities 202 10.4 0.92 0.72-1.18
Suburbs of big cities 352 20.3 2.14 1.71-2.68
Center of big cities 279 14.5 1.57 1.25-1.98
Age group
25-44 yrs. 417 13.8 1.00
18-24 yrs. 165 13.4 2.01 1.52-2.64
45-64 yrs. 392 12.5 0.56 0.45-0.71
> 65 yrs. 183 17.4 0.62 0.43-0.92
TC
TC < 5.17 mmol/L 662 11.6 1.00
TC ≥ 5.17 mmol/L &TC<6.24 mmol/L 319 15.8 1.04 0.85-1.26
TC ≥ 6.24 mmol/L 176 24.7 1.48 1.12-1.94
TG
TG < 1.69 mmol/L 479 8.4 1.00
TG ≥ 1.69 mmol/L &TG<2.26 mmol/L 207 18.0 1.76 1.39-2.22
TG ≥ 2.26 mmol/L &TG<5.65 mmol/L 399 28.8 2.83 2.30-3.49
TG ≥ 5.65 mmol/L 72 42.1 4.3 2.69-6.86
FG
Glu < 5.6 mmol/L 717 11.6 1.00
Glu ≥ 5.6 mmol/L &Glu<7.0 mmol/L 379 20.8 1.27 1.05-1.54
Glu ≥ 7.0 mmol/L 61 14.9 0.59 0.40-0.86
HTN
Normal 211 7.7 1.00
PreHTN 569 15.3 1.51 1.22-1.87
HTN 345 20.2 1.53 1.18-1.99
Obesity
Normal 426 9.1 1.00
Overweight 540 20.0 1.65 1.33-2.05
Obesity 150 30.1 2.42 1.73-3.39
CKD
eGFR≥90 ml/(min·1.73 m2) 754 12.7 1.00
eGFR≥60 ml/(min·1.73 m2) & eGFR<90 ml/(min·1.73 m2) 291 14.6 1.82 1.42-2.33
eGFR≥30 ml/(min·1.73 m2) & eGFR<60 ml/(min·1.73 m2) 86 30.0 6.34 3.96-10.13
eGFR<30 ml/(min·1.73 m2) 5 83.3 55.87 6.10-511.48
Abdominal obesity
Normal 496 9.5 1.00
Abdominal obesity 661 20.4 1.82 1.46-2.26
Drinking
Non-drinking 578 10.2 1.00
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Table 3 HUA risk factors in two Northern Chinese provinces (Continued)
Drinking 495 22.8 1.36 1.11-1.67
Quit drinking 33 16.9 1.07 0.65-1.77
Sleeping time
>8 hours 222 12.4 1.00
6-8 hours 681 14.1 1.07 0.88-1.31
4-6 hours 144 13.4 1.03 0.77-1.37
<4 hours 24 17.8 2.48 1.39-4.42
a Bold text indicates significance at P<0.05.
Abbreviations: TC total cholesterol, TG triglyceride, FG fasting glucose, HTN hypertension, CKD chronic kidney disease.
A stepwise logistic regression model was used to estimate odds ratios (ORs) with 95% confidence intervals (CIs) and all other factors were adjusted when estimate
odds ratios (ORs) with 95% confidence intervals (CIs) of each variable.
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logistic regression results have further confirmed the as-
sociation between metabolic abnormalities and HUA,
and have conducted further stratified analysis on each
metabolic abnormality-related indicator. Our results
have shown that TG and BMI are the most significant
contributing factors to HUA prevalence, and that when
TG ≥ 5.65 mmol/L, odds of HUA increase nearly 5-fold
compared with TG < 1.69 mmol/L. In addition, obese
participants have an HUA prevalence of 27.0%, while
normal weight subjects have a prevalence of 8.9%, mean-
ing that obese people have HUA prevalence 3.27 times
that of those of normal weight. For traditional vascular
disease risk factors like TC and LDL, to reach a certain
level results in a small increase in HUA odds. This sug-
gests that the lipids are involved in energy metabolism
and can increase purine biosynthesis and catabolism,
which can eventually contribute to HUA risk factors.
However, hardening of the arteries caused by abnormal
cholesterol that could cause kidney changes may not
greatly contribute to HUA. Fasting blood glucose impaired
patients have an HUA prevalence of 27.1%, but compared
with normal blood glucose (19.2%), the difference is not
significant. Although the HUA prevalence in high fasting
blood glucose patients reaches up to 15.2%, the odds ratio
reduces to 0.44, which may be because high fasting glu-
cose subjects have already been diagnosed with diabetes
and have already begun treatment. In stepwise multiple re-
gression, we found that elevated blood pressure is a risk
factor in women but not men. In addition, HUA preva-
lence in those pre-hypertensive and hypertensive were
twice the prevalence of normotensives. Further study is
needed to explore the differences of abnormal blood pres-
sure impact on HUA prevalence in men and women.
In addition to blood pressure, other differences in HUA
risk factors in different genders were obtained by stepwise
multiple regression. Unique risk factors for women were
mainly demographic characteristics such as marital status,
while unique risk factors for men were mainly personal
habits such as diet habits, smoking, alcohol consumption,and sleep time. This interesting phenomenon may indicate
that men have less concern for their health. If this is true,
active intervention measures to lower uric acid may be
more effective for men. In addition, the study also found
that participants from transportation and government
agencies had high HUA prevalence (19.7% and 19.2%). A
common feature of these two occupations is long periods
of sitting. Additionally, it may not be possible for transpor-
tation employees to urinate on time; whether this factor
could cause the increase of uric acid in renal tubular re-
absorption remains to be further explored.
The study had several limitations. The study is based on
a cross-sectional survey, which is unable to determine
causality or the temporal relationship between metabolism
indicators and HUA. In addition, parameters including
some lifestyle factors and educational status were not filled
in the questionnaire due to poor compliance of the local
population, which resulted in the correlation of these pa-
rameters and hyperuricemia were unable to be analyzed
completely because of a large amount of missing data.
Conclusions
In conclusion, the prevalence of HUA is high in northern
China. The differences in HUA prevalence by geographic
region presented here suggest that unbalanced economic
development and health education may underlie differ-
ences in health. The government is suggested to develop
programs to effectively control metabolic abnormalities, in-
cluding HUA. Our research also shows that personal habits
are closely associated with HUA. Additional attention
should be given to healthy lifestyles and early interventions
to control obesity and lipid abnormalities, to effectively re-
duce HUA risk and avoid the occurrence of gout.
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